CLINICAL_TRIALS
trial_result
· 2025-03-07
Clinical Trial Update: Efficacy of Letrozole in Recurrent Ovarian Cancer [Phase 3]
Summary
Phase 3 trial evaluating letrozole for recurrent epithelial ovarian cancer has been terminated; the update does not include efficacy results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Epithelial Ovarian Cancer | Phase 3 | Status: TERMINATED